Advanced basal cell carcinoma, the hedgehog pathway, and treatment options – role of smoothened inhibitors

por Fecher, Leslie A, Sharfman, William H
Publicado 2015

Bing‐Neel syndrome

por Davis, Katelynn, Sharfman, William H., Francischetti, Ivo M. B.
Publicado 2022

Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis

por Jain, Animesh, Lipson, Evan J, Sharfman, William H, Brant, Steven R, Lazarev, Mark G
Publicado 2017

Primary Small Cell Neuroendocrine Carcinoma of Paranasal Sinuses

por Khan, Maliha, Nizami, Sobia, Mirrakhimov, Aibek E., Maughan, Benjamin, Bishop, Justin A., Sharfman, William H.
Publicado 2014

Open-label, randomized, multi-center study comparing the sequence of high dose Aldesleukin (Proleukin(® )(HD IL-2) and Ipilimumab Yervoy(® )) in patients with metastatic melanoma (...

por Patel, Sapna, Milhem, Mohammed, Hallmeyer, Sigrun, Daniels, Gregory, Cranmer, Lee, Taback, Bret, Flaherty, Lawrence, Aung, Sandra, Lowder, James, Sharfman, William
Publicado 2014

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

por Lipson, Evan J., Lilo, Mohammed T., Ogurtsova, Aleksandra, Esandrio, Jessica, Xu, Haiying, Brothers, Patricia, Schollenberger, Megan, Sharfman, William H., Taube, Janis M.
Publicado 2017

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

por LoPiccolo, Jaclyn, Schollenberger, Megan D., Dakhil, Sumia, Rosner, Samuel, Ali, Osama, Sharfman, William H., Silk, Ann W., Bhatia, Shailender, Lipson, Evan J.
Publicado 2019

Adjuvant radiotherapy and outcomes of presumed hemorrhagic melanoma brain metastases without malignant cells

por Xia, Yuanxuan, Mashouf, Leila A., Maxwell, Russell, Peng, Luke C., Lipson, Evan J., Sharfman, William H., Bettegowda, Chetan, Redmond, Kristin J., Kleinberg, Lawrence R., Lim, Michael
Publicado 2018

Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

por Moseley, Kendall F., Naidoo, Jarushka, Bingham, Clifton O., Carducci, Michael A., Forde, Patrick M., Gibney, Geoffrey T., Lipson, Evan J., Shah, Ami A., Sharfman, William H., Cappelli, Laura C.
Publicado 2018

From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real‐world setting

por Rowe, Steven P., Luber, Brandon, Makell, Monique, Brothers, Patricia, Santmyer, JoAnn, Schollenberger, Megan D., Quinn, Hannah, Edelstein, Daniel L., Jones, Frederick S., Bleich, Karen B., Sharfman, William H., Lipson, Evan J.
Publicado 2018

An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma

por Hasanov, Merve, Milton, Denái R., Sharfman, William H., Taback, Bret, Cranmer, Lee D., Daniels, Gregory A, Flaherty, Lawrence, Hallmeyer, Sigrun, Milhem, Mohammed, Feun, Lynn, Hauke, Ralph, Doolittle, Gary, Gregory, Nancy, Patel, Sapna
Publicado 2021

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

por Lipson, Evan J, Sharfman, William H, Chen, Shuming, McMiller, Tracee L, Pritchard, Theresa S, Salas, January T, Sartorius-Mergenthaler, Susan, Freed, Irwin, Ravi, Sowmya, Wang, Hao, Luber, Brandon, Sproul, Janice Davis, Taube, Janis M, Pardoll, Drew M, Topalian, Suzanne L
Publicado 2015

A first‐in‐human phase I, multicenter, open‐label, dose‐escalation study of the oral RAF/VEGFR‐2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF...

por Izar, Benjamin, Sharfman, William, Hodi, F. Stephen, Lawrence, Donald, Flaherty, Keith T., Amaravadi, Ravi, Kim, Kevin B., Puzanov, Igor, Sosman, Jeffrey, Dummer, Reinhard, Goldinger, Simone M., Lam, Lyhping, Kakar, Shefali, Tang, Zhongwen, Krieter, Oliver, McDermott, David F., Atkins, Michael B.
Publicado 2017

Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade

por Naidoo, Jarushka, Cappelli, Laura C., Forde, Patrick M., Marrone, Kristen A., Lipson, Evan J., Hammers, Hans J., Sharfman, William H., Le, Dung T., Baer, Alan N., Shah, Ami A., Albayda, Jemima, Manno, Rebecca L., Haque, Uzma, Gutierrez, Anna Kristina, Bingham, Clifton O., Brahmer, Julie R.
Publicado 2017

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

por Ferris, Robert L, Spanos, William C, Leidner, Rom, Gonçalves, Anthony, Martens, Uwe M, Kyi, Chrisann, Sharfman, William, Chung, Christine H, Devriese, Lot A, Gauthier, Helene, Chiosea, Simon I, Vujanovic, Lazar, Taube, Janis M, Stein, Julie E, Li, Jun, Li, Bin, Chen, Tian, Barrows, Adam, Topalian, Suzanne L
Publicado 2021

Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218)

por Hodi, F. Stephen, Chapman, Paul B., Sznol, Mario, Lao, Christopher D., Gonzalez, Rene, Smylie, Michael, Daniels, Gregory A., Thompson, John A., Kudchadkar, Ragini, Sharfman, William, Atkins, Michael, Spigel, David R., Pavlick, Anna, Monzon, Jose, Kim, Kevin B., Ernst, Scott, Khushalani, Nikhil I., van Dijck, Wim, Lobo, Maurice, Hogg, David
Publicado 2020

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

por Nghiem, Paul, Bhatia, Shailender, Lipson, Evan J, Sharfman, William H, Kudchadkar, Ragini R, Brohl, Andrew S, Friedlander, Philip A, Daud, Adil, Kluger, Harriet M, Reddy, Sunil A, Boulmay, Brian C, Riker, Adam, Burgess, Melissa A, Hanks, Brent A, Olencki, Thomas, Kendra, Kari, Church, Candice, Akaike, Tomoko, Ramchurren, Nirasha, Shinohara, Michi M, Salim, Bob, Taube, Janis M, Jensen, Erin, Kalabis, Mizuho, Fling, Steven P, Homet Moreno, Blanca, Sharon, Elad, Cheever, Martin A, Topalian, Suzanne L
Publicado 2021

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0

por Sullivan, Ryan J., Atkins, Michael B., Kirkwood, John M., Agarwala, Sanjiv S., Clark, Joseph I., Ernstoff, Marc S., Fecher, Leslie, Gajewski, Thomas F., Gastman, Brian, Lawson, David H., Lutzky, Jose, McDermott, David F., Margolin, Kim A., Mehnert, Janice M., Pavlick, Anna C., Richards, Jon M., Rubin, Krista M., Sharfman, William, Silverstein, Steven, Slingluff, Craig L., Sondak, Vernon K., Tarhini, Ahmad A., Thompson, John A., Urba, Walter J., White, Richard L., Whitman, Eric D., Hodi, F. Stephen, Kaufman, Howard L.
Publicado 2018

Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

por Smith, Kellie N., Llosa, Nicolas J., Cottrell, Tricia R., Siegel, Nicholas, Fan, Hongni, Suri, Prerna, Chan, Hok Yee, Guo, Haidan, Oke, Teniola, Awan, Anas H., Verde, Franco, Danilova, Ludmila, Anagnostou, Valsamo, Tam, Ada J., Luber, Brandon S., Bartlett, Bjarne R., Aulakh, Laveet K., Sidhom, John-William, Zhu, Qingfeng, Sears, Cynthia L., Cope, Leslie, Sharfman, William H., Thompson, Elizabeth D., Riemer, Joanne, Marrone, Kristen A., Naidoo, Jarushka, Velculescu, Victor E., Forde, Patrick M., Vogelstein, Bert, Kinzler, Kenneth W., Papadopoulos, Nickolas, Durham, Jennifer N., Wang, Hao, Le, Dung T., Justesen, Sune, Taube, Janis M., Diaz, Luis A., Brahmer, Julie R., Pardoll, Drew M., Anders, Robert A., Housseau, Franck
Publicado 2019

Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

por Smith, Kellie N., Llosa, Nicolas J., Cottrell, Tricia R., Siegel, Nicholas, Fan, Hongni, Suri, Prerna, Chan, Hok Yee, Guo, Haidan, Oke, Teniola, Awan, Anas H., Verde, Franco, Danilova, Ludmila, Anagnostou, Valsamo, Tam, Ada J., Luber, Brandon S., Bartlett, Bjarne R., Aulakh, Laveet K., Sidhom, John-William, Zhu, Qingfeng, Sears, Cynthia L., Cope, Leslie, Sharfman, William H., Thompson, Elizabeth D., Riemer, Joanne, Marrone, Kristen A., Naidoo, Jarushka, Velculescu, Victor E., Forde, Patrick M., Vogelstein, Bert, Kinzler, Kenneth W., Papadopoulos, Nickolas, Durham, Jennifer N., Wang, Hao, Le, Dung T., Justesen, Sune, Taube, Janis M., Diaz Jr, Luis A., Brahmer, Julie R., Pardoll, Drew M., Anders, Robert A., Housseau, Franck
Publicado 2019